详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Gene therapy: New and future treatments for uveitis

文献详情

资源类型：

作者：

机构： [1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, China

出处：

DOI：

关键词： ASO CRISPR gene therapy RNAi uveitis

语种：

第一作者：

第一作者机构： [1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, China

通讯作者：

通讯机构： [1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Public Attitudes toward Gene Therapy in China [2]In vivo gene therapy potentials of CRISPR-Cas9 [3]CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation [4]B7基因与肿瘤免疫基因治疗的研究进展 [5]Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy [6]crispr/cas9系统在晶状体相关疾病发病机制研究中的应用 [7]头颈恶性肿瘤的基因治疗 [8]In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer [9]IL-10: A Key Regulator and potential therapeutic target in uveitis [10]Antagonism between gene therapy and epigenetic therapy on human laryngeal carcinoma tumor-bearing mice